Abstract
Introduction
Blood pressure (BP) variability (BPV) has emerged as an indicator of subclinical organ damage and an independent predictor of cardiovascular disease (CVD) morbidity and mortality in high-risk populations.
Aim
We aimed to assess short-term variability of both brachial and aortic BP in psoriasis, a common immune-mediated inflammatory disorder characterized by increased CVD risk.
Methods
Psoriasis patients and non-psoriasis individuals had their BP assessed throughout a 24 h period (Mobil-O-Graph device). Brachial and aortic BPV during the 24 h and the respective daytime and nighttime periods was calculated from relevant ambulatory BP profiles. In-house software was applied to automatically calculate average real variability (ARV) of brachial and aortic systolic (bSBP, aSBP) and diastolic BP (bDPB, aDBP), and the weighted standard deviation (wSD) of 24 h bSBP/aSBP. 24 h pulse wave velocity (PWV) and augmentation index (AIx) were used as widely applied markers of arterial stiffness.
Results
Psoriasis patients (n = 74) presented increased ARV of 24 h and daytime bSBP/aSBP, and increased ARV of 24 h and daytime bDBP/aDBP, compared to controls (n = 40). PWV and AIx correlated with ARV of 24 h bSBP/aSBP, daytime bSBP/aSBP, while PWV further correlated with ARV of nighttime aSBP. The observed associations with PWV, yet not AIx, with indices of BPV remained significant after adjusting for CVD risk factors.
Conclusions
This is the first study reporting increased 24 h variability of both brachial and aortic BP in psoriasis. The association of short-term BPV with arterial stiffness implies a potential role of BPV in terms of CVD risk stratification in patients with chronic immune-mediated inflammation.
Similar content being viewed by others
Data Availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
Boehncke WH, Schön MP. Psoriasis. Lancet. 2015;386(9997):983–94. https://doi.org/10.1016/S0140-6736(14)61909-7.
Masson W, Lobo M, Molinero G. Psoriasis and cardiovascular risk: a comprehensive review. Adv Ther. 2020;37(5):2017–33. https://doi.org/10.1007/s12325-020-01346-6.
Puig L. Cardiometabolic comorbidities in psoriasis and psoriatic arthritis. Int J Mol Sci. 2018. https://doi.org/10.3390/ijms19010058.
Ahlehoff O, Gislason G, Hansen PR. Cardiovascular aspects of psoriasis: an updated review. Int J Dermatol. 2014;53(6):153–62. https://doi.org/10.1111/ijd.12267.
Margouta A, Anyfanti P, Lazaridis A, Nikolaidou B, Mastogiannis K, Malliora A, Patsatsi A, Triantafyllou A, Douma S, Doumas M, Gkaliagkousi E. Blunted microvascular reactivity in psoriasis patients in the absence of cardiovascular disease, as assessed by laser speckle contrast imaging. Life. 2022;12(11):1796. https://doi.org/10.3390/life12111796.
Margouta A, Anyfanti P, Lazaridis A, Gavriilaki E, Yiannaki E, Nikolaidou B, Goulas K, Lazaridou E, Triantafyllou A, Douma S, Patsatsi A, Gkaliagkousi E. Assessment of microvesicles from different cell origins in patients with psoriasis: evidence of thrombogenic, proinflammatory microenvironment in the absence of established cardiovascular disease. J Hum Hypertens. 2022. https://doi.org/10.1038/s41371-022-00787-6.
Anyfanti P, Margouta A, Goulas K, Gavriilaki M, Lazaridou E, Patsatsi A, Gkaliagkousi E. Endothelial dysfunction in psoriasis: an updated review. Front Med. 2022;9(June):1–10. https://doi.org/10.3389/fmed.2022.864185.
Kannel WB. Historic perspectives on the relative contributions of diastolic and systolic blood pressure elevation to cardiovascular risk profile. Am Heart J. 1999;138(3):S205–10. https://doi.org/10.1016/S0002-8703(99)70311-X.
Glynn RJ, L’Italien GJ, Sesso HD, Jackson EA, Buring JE. Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension. 2002;39(1):105–10. https://doi.org/10.1161/hy1201.097199.
Vlachopoulos C, Aznaouridis K, O’Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J. 2010;31(15):1865–71. https://doi.org/10.1093/eurheartj/ehq024.
Madden JM, O’Flynn AM, Fitzgerald AP, Kearney PM. Correlation between short-term blood pressure variability and left-ventricular mass index: a meta-analysis. Hypertens Res. 2016;39(3):171–7. https://doi.org/10.1038/hr.2015.126.
Chi C, Yu SK, Auckle R, Argyris AA, Nasothimiou E, Tountas C, Aissopou E, Blacher J, Safar ME, Sfikakis PP, Zhang Y, Protogerou AD. Association of left ventricular structural and functional abnormalities with aortic and brachial blood pressure variability in hypertensive patients: THE SAFAR study. J Hum Hypertens. 2017;31(10):633–9. https://doi.org/10.1038/jhh.2017.37.
Schillaci G, Bilo G, Pucci G, Lautrent S, MacQuin-Mavier I, Boutouyrie P, Battista F, Settimi L, Desamericq G, Dolbeau G, Faini A, Salvi P, Mannarino E, Parati G. Relationship between short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databases. Hypertension. 2012;60(2):369–77. https://doi.org/10.1161/HYPERTENSIONAHA.112.197491.
Shintani Y, Kikuya M, Hara A, Ohkibo T, Metoki H, Asayama K, Inoue R, Obara T, Aono Y, Hashimoto T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. Ambulatory blood pressure, blood pressure variability and the prevalence of carotid artery alteration: the Ohasama study. J Hypertens. 2007;25(8):1704–10. https://doi.org/10.1097/HJH.0b013e328172dc2e.
Yu S, Chi C, Protogerou AD, Safar ME, Blacher J, Argyris AA, Nasothimiou EG, Sfikakis PP, Ppapaioanou TG, Xu H, Zhang Y, Xu Y. 24-hour aortic blood pressure variability showed a stronger association with carotid damage than 24-hour brachial blood pressure variability: the SAFAR study. J Clin Hypertens. 2018;20(3):499–507. https://doi.org/10.1111/jch.13226.
Chen Y, **ong H, Wu D, Pirbhulal S, Tian X, Zhang R, Lu M, Wu W, Huang W. Relationship of short-term blood pressure variability with carotid intima-media thickness in hypertensive patients. Biomed Eng Online. 2015;14(1):1–15. https://doi.org/10.1186/s12938-015-0059-8.
Manios E, Tsagalis G, Tsivgoulis G, Barlas G, Koroboki E, Michas F, Alexaki E, Vemmos K, Zakopoulos K. Time rate of blood pressure variation is associated with impaired renal function in hypertensive patients. J Hypertens. 2009;27(11):2244–8. https://doi.org/10.1097/HJH.0b013e328330a94f.
** X, Lu Y, Zhao P. The correlation of blood pressure variability and cognitive function in hypertension patients: A meta-analysis. Int J Clin Pract. 2021;75:12. https://doi.org/10.1111/ijcp.14885.
Palatini P, Reboldi G, Beilin LJ, Casiglia E, Eguchi K, Imai Y, Kario K, Ohkubo T, Pierdomenico SD, Schwartz JE, Wing L, Verdecchia P. Added predictive value of night-time blood pressure variability for cardiovascular events and mortality: The ambulatory blood pressure-international study. Hypertension. 2014;64(3):487–93. https://doi.org/10.1161/HYPERTENSIONAHA.114.03694.
Parati G, Bilo G, Kollias A, Pengo M, Ochoa JE, Castiglioni P, Stergiou GS, Mancia G, Asayama K, Asmar R, Avolio A, Caiani EG, De La Sierra A, Dolan E, Grillo A, Guzic P, Hoshide S, Head GA, Imai Y, Juhanoja E, Kahan T, Kario K, Kotsis V, Kreutz R, Kyriakoulis KG, Li Y, Manios E, Mihailidou AS, Modesti PA, Omboni S, Palatini P, Persu A, Protogerou AD, Saladini F, Salvi P, Sarafidis P, Torlasco C, Veglio F, Vlachopoulos C, Zhang Y. Blood pressure variability: methodological aspects, clinical relevance and practical indications for management—a European Society of Hypertension position paper. J Hypertens. 2023. https://doi.org/10.1097/HJH.0000000000003363.
Saladini F, Fania C, Mos L, Vriz O, Mazzer A, Spinella P, Garavelli G, Ermolao A, Rattazzi M, Palatini P. Short-term but not long-term blood pressure variability is a predictor of adverse cardiovascular outcomes in young untreated hypertensives. Am J Hypertens. 2020;33(11):1030–7. https://doi.org/10.1093/ajh/hpaa121.
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Champan MJ, De Becker GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O, ESH Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–88. https://doi.org/10.1093/eurheartj/ehz455.
ElSayed NA, Aleppo G, Aroda VR, Bonnuru RR, Brown FM, Bruemmer D, Collins BS, Gaglia JL, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Standon RC, Gabbay RA. 2. Classification and diagnosis of diabetes: standards of care in diabetes—2023. Diabetes Care. 2023;46(Suppl 1):S19–40. https://doi.org/10.2337/dc23-S002.
Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszeicz A, Muisesan ML, Tsioufis K, Agabiti-Rosei E, Algharably EAE, Azizi M, Benetos A, Borghi C, Hitij JB, Cifkova R, Coca A, Cornelissen V, Cruickshank K, Cunja PG, Danser AHJ, de Pinho RA, Delles C, Dominiczak AF, Dorobantu M, Doumas M, Fernádez-Alfonso MA, Halimi JM, Járai Z, Jelaković B, Jordan J, Kuznetsova T, Laurent S, Lovic D, Lurbe E, Mahfoud F, Manolis A, Miglinas M, Narkiewicz K, Niiranen T, Palatini P, Pathak A, Persu A, Polonia J, Redon J, Sarafidis P, Schmieder R, Spronck B, Stabouli S, Stergiou G, Taddei S, Thomopoulos C, Tomaszewski M, Van de Borne P, WannerWeberWilliams CTB, Zhang ZY, Sjeldsen SE. ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertensi. J Hypertens. 2023. https://doi.org/10.1097/HJH.0000000000003480.
Schmitt J, Wozel G. The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology. 2005;210(3):194–9. https://doi.org/10.1159/000083509.
Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement D, Coca A, De Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen S, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder R, Shlyakhto E, Tsioufis K, Aboyans V, Desormais I. 2018 ESC/ESH Guidelines for the management of arterial hypertension. J Hypertens. 2018;36(10):1953–2041. https://doi.org/10.1097/HJH.0000000000001940.
Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness. J Am Coll Cardiol. 2010;55(13):1318–27. https://doi.org/10.1016/j.jacc.2009.10.061.
Mena L, Pintos S, Queipo NV, Aizpúrua JA, Maestre G, Sulbarán T. A reliable index for the prognostic significance of blood pressure variability. J Hypertens. 2005;23(3):505–11. https://doi.org/10.1097/01.hjh.0000160205.81652.5a.
Papadopoulou S-L, Gkaliagkousi E, Dipla K, Koletsos N, Zafeiridis A, Zabulis X, Lazaridis A, Stergiou G, Douma S, Triantafyllou A. Relationship of 24-h ambulatory blood pressure variability with micro and macrovascular parameters and hypertension status. J Hypertens. 2023;41(1):74–82. https://doi.org/10.1097/HJH.0000000000003300.
Reese T, Dickson AL, Shuey MM, Gandelman JS, Barnado A, Barker KA, Neal JE, Khan OA, Dupont WD, Stein CM, Chung CP. Increased blood pressure visit-to-visit variability in patients with systemic lupus erythematosus: association with inflammation and comorbidity burden. Lupus. 2019;28(8):954–60. https://doi.org/10.1177/0961203319856988.
Stojan G, Magder LS, Petri M. Blood pressure variability and age-related blood pressure patterns in systemic lupus erythematosus. J Rheumatol. 2020;47(3):387–93. https://doi.org/10.3899/jrheum.181131.
Myasoedova E, Crowson CS, Green AB, Matteson EL, Gabriel SE. Longterm blood pressure variability in patients with rheumatoid arthritis and its effect on cardiovascular events and all-cause mortality in RA: a population-based comparative cohort study. J Rheumatol. 2014;41(8):1638–44. https://doi.org/10.3899/jrheum.131170.
Gkaliagkousi E, Anyfanti P, Chatzimichailidou S, Triantafyllou A, Lazaridis A, Aslanidis S, Douma S. Association of nocturnal blood pressure patterns with inflammation and central and peripheral estimates of vascular health in rheumatoid arthritis. J Hum Hypertens. 2018;32(4):259–67. https://doi.org/10.1038/s41371-018-0047-0.
Kim K-I, Lee J-H, Chang H-J, Cho Y-S, Youn T-J, Chung W-Y, Chae I-H, Choi D-J, Park K-U, Kim C-H. Association between blood pressure variability and inflammatory marker in hypertensive patients. Circ J. 2008;72(2):293–8. https://doi.org/10.1253/circj.72.293.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Ethical approval
The study was approved by the Aristotle University Ethics Committee and held in accordance with the Declaration of Helsinki.
Funding
No funding was received.
Rights and permissions
About this article
Cite this article
Anyfanti, P., Triantafyllou, A., Lazaridis, A. et al. Short-Term Variability of Both Brachial and Aortic Blood Pressure is Increased in Patients with Immune-mediated Chronic Inflammation. High Blood Press Cardiovasc Prev (2024). https://doi.org/10.1007/s40292-024-00651-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s40292-024-00651-3